SARS-CoV-2 variants have developed resistance to human interferons

Genetics weigh heavy on childhood cancer survivors’ risk of developing obesity
25 July 2022
Twitter health amplifiers combat COVID-19 misinformation
25 July 2022

SARS-CoV-2 variants have developed resistance to human interferons

Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in Proceedings of the National Academy of Sciences, focuses on how the innate arm of the immune system defends against this coronavirus. The work resulted from a collaborative effort by multiple scientists, including the laboratories of Mario Santiago, Ph.D., associate professor of medicine and Eric Poeschla, MD, professor of medicine, both at the University of Colorado School of Medicine.

Comments are closed.